MET vs OVID · P/E 13, rev $38.23B vs rev $733.0K
MetLife Inc (MET) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
MET currently screens at market cap $52.16B and trailing P/E 12.7. OVID currently screens at market cap $23.5M.
Not investment advice. Open the MET and OVID stock pages for the full models.
Not investment advice.